← Back to Search

Group Physical Therapy for Knee Osteoarthritis (Group PT Trial)

N/A

Waitlist Available

Led By Courtney H Van Houtven, PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Must not have

Sites currently offering a group class specifically for knee OA will not be eligible to participate

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months (cumulative)

Awards & highlights

No Placebo-Only Group

Summary

This trial will compare implementation strategies for Group PT in 16 VA sites, and also gather information about the clinical intervention and related outcomes.

Who is the study for?

This trial is for VA sites with staff to evaluate and lead group physical therapy, outpatient PT service, space for group sessions, and a signed agreement. Sites already offering knee OA classes or previously in Function QUERI are excluded.

What is being tested?

The study tests two strategies (Foundational REP and Enhanced REP) to implement Group Physical Therapy at 16 VA sites for veterans with knee osteoarthritis using an effectiveness-implementation hybrid design framework.

What are the potential side effects?

Since this trial focuses on the implementation of physical therapy rather than a drug intervention, it does not directly involve medication side effects. However, participants may experience typical physical therapy-related discomforts.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My treatment center does not offer group classes for knee osteoarthritis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months (cumulative)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months (cumulative)

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months (cumulative) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Penetration

Secondary study objectives

Adoption

Fidelity

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Enhanced REPExperimental Treatment1 Intervention

EnREP begins with the same activities as foundational REP. Sites that do not meet EBP-specific a priori benchmarks reflecting adoption within 6 months will continue with foundational REP and will receive higher intensity support for a period of 6 months (enREP). Additionally, sites randomized to enREP that met adoption benchmarks but did do not meet the sustainment benchmark, will also receive intensified implementation support for the remainder of the study period (3 months). The higher intensity support will include one-on-one calls approximately every 3 to 4 weeks between site implementation teams and a trained practice facilitator (from Function QUERI team). The facilitator will coach individual sites using techniques, processes, and activities to help teams make decisions and identify and solve problems. Facilitators? actions will depend on each site?s needs and clinical context.

Group II: Foundational REPActive Control1 Intervention

Foundational REP uses the Replicating Effective Program implementation strategy and includes 5 elements that were developed and tested in our prior Function QUERI work: Stakeholder engagement; Toolkit; SharePoint access for clinical program training materials; Data dashboard to assist sites with tracking their own data; and Diffusion Networks to promote peer-to-peer sharing and implementation support.

0 / 1Eligibility criteria met